Using PET/CT and biomarkers to guide treatment decisions: a case study

Imaging techniques, such as positron emission tomography–computed tomography (PET/CT), and biomarkers can play vital roles in the clinical assessment of patients at diagnosis and following treatment. This case study, presented by Professor Kwee Yong from University College London, illustrates how the latter may be used to inform treatment selection.

The views expressed in this video are those of the speaker.

Presented at a Takeda meeting.

UK/NP/1806/0035(1)k - November 2018

You are now leaving the Myeloma Hub

This link opens another website that is not under the review or control of Takeda UK Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it. Please confirm you wish to continue.